Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • PR Newswire Amplify™
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • IR
  • All Products
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Hamburger menu
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • IR
  • All Products
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • Sign Up
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media Enquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR

Astounding success for the 24th edition of the Tour CIBC Charles-Bruneau Français

Logo: Tour CIBC Charles-Bruneau (CNW Group/Fondation Charles-Bruneau)

News provided by

Fondation Charles-Bruneau

Jul 05, 2019, 19:09 ET

Share this article

Share toX

Share this article

Share toX

$5 350 000 raised for children with cancer

BOUCHERVILLE, QC, July 5, 2019 /CNW Telbec/ - Amid a festive and euphoric atmosphere, the 850 cyclists in the 24th Tour CIBC Charles-Bruneau were warmly welcomed today by their families, friends and colleagues as they arrived at their final destination after travelling more than 2,345 kilometers across Quebec with the shared hope of putting an end to pediatric cancer.

Continue Reading
Astounding success for the 24th edition of the Tour CIBC Charles-Bruneau - $5 350 000 raised for children with cancer (CNW Group/Fondation Charles-Bruneau)
Astounding success for the 24th edition of the Tour CIBC Charles-Bruneau - $5 350 000 raised for children with cancer (CNW Group/Fondation Charles-Bruneau)

The event's eleven spokespersons – Pierre and Ginette Bruneau, Paul Doucet, Pierre Jobin, Luce Dufault, Alexandre Dubé, Hugo Giroux, Louis Jean, Julie Marcoux and Lex Albrecht – and all the cyclists who took part in the Tour celebrated the incredible success of this major cycling event, which far surpassed its objective by raising a record $5.35 million. The proceeds will go towards the development of projects in the area of pediatric hematology and oncology.

In order to encourage the cyclists during the course of the event and attest to the importance of investing in pediatric oncology research, the cyclists received support from children with cancer or in remission. Taking part in this year's event with their parents were Kenley Bien Aimé, 18, in treatment of lymphoblastic lymphoma, Enzo Hamel, 14, in remission of a chondrosarcoma, Yasmine El Hassani, 10, in remission of a cerebral geminoma, Pénélope Phaneuf, 8, in treatment of acute lymphoblastic leukemia, Maxime Guénette, 10, diagnosed acute lymphoblastic leukemia, Élizabeth St-Georges, 7, in remission of Still's disease, Naomie Fontaine, 9, in remission of an osteosarcoma to the right femur, and about 60 other children paired with the cyclists taking part in the 24th edition. 

The 2019 Tour CIBC Charles-Bruneau in numbers

  • 24th edition
  • The 2019 edition took place on June 8 and from July 2 to 5, 2019
  • 10 separate treks
  • Close to 2,345 km
  • More than 850 motivated cyclists
  • More than 200 involved volunteers
  • More than 70 courageous families
  • More than $29 million raised since the first Tour in 1995
  • $4.5 million raised in 2018
  • 2019 objective: more than $4.5 million
  • 2019 result: $5.35 million
  • Next edition: July 5-10, 2020

Quotes

Pierre Bruneau, TVA news anchor and spokesperson for the Charles-Bruneau Foundation
"What a pleasure to see that this year again, Quebec has responded to our call! It's an all-time record and we can all be proud of it. We have amassed a staggering amount thanks to the unparalleled number of cyclists who have committed to the cause. This collective dedication allows us to continue our mission and continue to support pediatric hemato-oncology research units in Quebec. Thank you to each of the 850 cyclists, our 200 devoted volunteers, our valued partners and each one of you who, through your donations and encouragement, allow us to offer hope to all children with cancer in Quebec. Thank you so much ! "

Sylvain Vinet, CIBC Senior Vice-President and Region Head, Eastern Canada Region & Vice-President of the Charles-Bruneau Foundation Board of Directors
"Each year, the effect of Tour CIBC Charles Bruneau is felt in our banking centres and offices across the province. In addition to lots of fundraising activities taking place, this year, more than 100 employees will cycle for the cause. Team CIBC is so proud to have been a partner of the Fondation for 14 years now, and we thank everyone who supports the children who are the real heroes of this story. It is heart-warming and inspiring to come together with our clients and communities for a common purpose. Together we are One for Change! " 

Aside from the cyclists who spared no effort to reach this new record, the event could not have been so successful without the extraordinary involvement of 4 major partners, that the Charles-Bruneau Foundation would like to wholeheartedly thank: CIBC, IGA, Cascades and Lowe's Canada.

Pediatric cancer in Quebec

  • Nearly one child a day is diagnosed with cancer in Quebec
  • Cancer is the leading cause of death due to illness among children aged 0 to 18
  • More than half of children with cancer are diagnosed before the age of 5

About the Charles-Bruneau Foundation
The Charles-Bruneau Foundation is proud to be the largest funder of pediatric hematology oncology research in Quebec.
The latest commitments announced are necessary to allow major breakthroughs in research.

  • By 2022: $22 million will be invested in the Unité de recherche en hémato-oncologie pédiatrique Charles-Bruneau at CHU Sainte-Justine
  • $4 million will also be donated to the Montreal Children's Hospital.

Two objectives will serve to guide researchers: finding a cure for the 20% of children whose cancer is resistant to treatment, and improving the quality of life of children in remission so that they can enjoy a true recovery. While these commitments are ambitious, the Foundation is confident that it can count on its loyal partners and the people.

Over the past 29 years, the sum of $15 million has been invested in research, and an additional $40 million has gone toward the construction, procurement and development of a Cancer Centre, a research centre and three Charles-Bruneau units in Quebec.

SOURCE Fondation Charles-Bruneau

Véronique Blais, TACT Intelligence-conseil, Cell.: 514-241-2686, [email protected]

Modal title

Organization Profile

Fondation Charles-Bruneau

    Also from this source

  • The Fondation Charles-Bruneau announces an historic commitment

Contact Cision

  • 866-245-2317
    from 8 AM - 10 PM ET
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Platform Login
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2025 CNW Group Ltd. All Rights Reserved. A Cision company.